2009 NCRI Conference
Dr Ester Hammond, Gray Institute for Radiation Oncology and Biology, Oxford
New uses for PARP inhibitors
Larry Norton at the NCRI Cancer Conference 2009
The PARSPORT trial - radiotherapy for head and neck cancer
Circulating tumour cells and biomarkers
Imunotherapy for treating childhood neuroblastoma
The need for better clinical trials for cancer treatments
New uses for PARP inhibitorsDr Hammond talks about her research showing that PARP inhibitor drugs could be used to treat cancers that have low levels of oxygen (hypoxia)
Improving pain relief for people with cancer
Prior to the 2009 NCRI Conference - Interview with Sir Kenneth
Please note: all of these videos use the latest Flash plugin. You will need to have Flash 8 or greater to view this content. To get this free player, click here.
